Kintsugi 440mg Injection

Overview Kintsugi 440mg Injection

Herceptin-equivalent injection (440mg) is indicated for managing breast and gastric cancers. Its mechanism involves targeted cell death via HER2 receptor inhibition. Administration is strictly intravenous, performed by a healthcare professional. Dosage and frequency are individually determined by your physician, varying based on treatment needs and potentially adjusted over time. Adhere precisely to the prescribed regimen; deviations can lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue only under physician supervision. Common side effects encompass nausea, headache, skin rashes, sleep disturbances, and infections. Leukopenia and thrombocytopenia are potential risks, increasing infection vulnerability. Regular monitoring of blood counts, cardiac function, hepatic status, and uric acid levels is essential. Report immediately any shortness of breath, cough, chills, or limb edema. Inform your medical team of all concomitant medications, as interactions may occur. This treatment is contraindicated during pregnancy and lactation; reliable contraception for both partners is crucial throughout the treatment period.

Uses of Kintsugi 440mg Injection

Cancers affecting the breast and stomach

Major Benefits of Kintsugi 440mg Injection:

This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

Common Side effects of Kintsugi 440mg Injection:

• Anemia (low number of red blood cells)
• Chills
• Common cold
• Cough
• Decreased blood cells (red cells, white cells, and platelets)
• Diarrhea
• Fatigue
• Fever
• Headache
• Heart failure
• Infection
• Insomnia (difficulty in sleeping)
• Mucosal inflammation
• Nausea
• Rash
• Stomatitis (Inflammation of the mouth)
• Taste change
• Upper respiratory tract infection
• Weight loss

How to use Kintsugi 440mg Injection:

This medication will be administered by your physician or their qualified staff. Self-medication is strongly discouraged.

How Kintsugi 440mg Injection works:

Kintsugi 440mg Injection, a recombinant IgG1 monoclonal antibody, targets HER2 (human epidermal growth factor receptor 2) receptors. By binding to these receptors, prevalent in breast and gastric cancers, it prevents excessive cancer cell growth. This action directly destroys cancer cells and simultaneously disrupts multiple downstream signaling pathways implicated in cancer development.

What if you forget to take Kintsugi 440mg Injection :

Should you forget a scheduled dose of Kintsugi 440mg Injection, seek your physician's advice.